A covalent organic framework nano-chelator orchestrates multitarget clearance of Alzheimer’s pathologies
- 2 April 2026
- journal article
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 717, 140451
Abstract
No abstract availableKeywords
Funding Information
- Hebei Provincial Department of Science and Technology (226Z2601G)
- Hebei Medical University (2022LCTD-B32)
This publication has 43 references indexed in Scilit:
- A Decade‐Long Journey in Design Strategies and Structure–Property Relationships of Covalent Organic Framework Nanocarriers for Anticancer Drug DeliverySmall, 2025
- Capsaicin Alleviates Autophagy‐Lysosomal Dysfunction via PPARA‐Mediated V‐ATPase Subunit ATP6V0E1 Signaling in 3xTg‐AD MiceAdvanced Science, 2025
- Bimetallic Cu/Zn Single‐Atom Nanozyme with Superoxide Dismutase‐Like ActivitySmall, 2025
- Nanotechnology in the diagnostic and therapy for Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2024
- Multifunctional Nanotheranostics for Overcoming the Blood–Brain BarrierAdvanced Functional Materials, 2024
- A novel AD theranostic platform with NIR-II laser controlled drug release and real-time monitoring of therapeutic outcomesChemical Engineering Journal, 2023
- Engineered urinary-derived extracellular vesicles loaded nanoenzymes as Trojan horses to regulate the inflammatory microenvironment for treatment of Alzheimer's diseaseChemical Engineering Journal, 2023
- The Current Status of MOF and COF ApplicationsAngewandte Chemie International Edition, 2021
- Alzheimer's disease amyloid beta peptides in vitro electrochemical oxidationBioelectrochemistry, 2017
- Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Aβ) of Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2006